A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 35 (1) , 176-182
- https://doi.org/10.1016/s0735-1097(99)00494-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inhaled nitric oxide in primary pulmonary hypertensionJournal of the American College of Cardiology, 1998
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary HypertensionCirculation, 1997
- Clinical Significance of the Pulmonary Vasodilator Response During Short-term Infusion of Prostacyclin in Primary Pulmonary HypertensionCirculation, 1996
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Myocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandinsCardiovascular Research, 1995
- Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertensionThe Lancet, 1991
- Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.Circulation, 1991
- Prostacyclin and Iloprost — Thrombosis and AtherosclerosisPublished by Springer Nature ,1987
- Chemistry of Stable Prostacyclin Analogues: Synthesis of IloprostPublished by Springer Nature ,1987